Showing all 2 results
Alprazolam & Sertraline Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Sertraline (as HCl) USP/BP 25 mg / 50 mg The Antidepressant Anchor: Provides long-term correction of serotonin levels to treat depression and OCD. Alprazolam USP/BP 0.25 mg / 0.5 mg The Anxiolytic Bridge: Provides rapid relief from acute anxiety and prevents panic spikes. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid release of Alprazolam for immediate relief while Sertraline maintains steady-state plasma levels. Escitalopram Oxalate & Clonazepam Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.
Active Ingredient Strength Primary Clinical Function Escitalopram (as Oxalate) USP/Ph.Eur. 5 mg / 10 mg The Serotonin Anchor (Macro-Dose): The foundational, highly selective SSRI required to cure the underlying clinical depression and generalized anxiety. Clonazepam USP/Ph.Eur. 0.25 mg / 0.5 mg The Anxiolytic Bridge (Micro-Dose): The highly potent, long-acting benzodiazepine required to suppress acute panic attacks and SSRI-induced activation syndrome. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / High-Shear Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the lethal 0.25mg/0.5mg micro-dose of Clonazepam is flawlessly distributed throughout the Escitalopram matrix, preventing toxic “hot spots”) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 2-to-4 week short-term bridging regimens before stepping down to Escitalopram monotherapy).
